embers ventures.

Capital that builds its way out.

Embers Ventures invests, takes charge of accelerating revenue, and writes the exit into the deal from day one — a pre-agreed path for founders to take back every share we hold.

We invest at both ends of a life: fertility and longevity, built on computational intelligence, autonomous systems, and engineered biology.

Explore → The focus The model Revenue mandate Where we run deep In the work

01 The focus

Where breakthroughs become markets.

We back founders applying frontier technologies to fertility and longevity — the two demographic forces reshaping this century — and partner with select pre-IPO companies where our market access can turn innovation into accelerated growth.

The demographics are not subtle: sperm counts have fallen more than 50% in five decades and the decline is accelerating; the WHO estimates 1 in 6 adults experience infertility; and by 2050 the number of people over 60 will double to 2.1 billion — a cohort already generating roughly a third of global GDP.

Levine et al., Human Reproduction Update · WHO · AARP Global Longevity Economy

And because companies now reach the public markets a decade or more after founding — median age at IPO has roughly tripled since 1999 — the growth that once accrued to public investors is captured private. That is where market access matters most, and where we spend ours.

02 Frontier technologies — the double click

Three technologies. One generational repricing of what's possible.

Frontier i

Computational intelligence

Systems that learn, reason, and decide — collapsing the cost of prediction, personalization, and expertise itself. Applied to health, it turns population-level science into individual-level guidance.

McKinsey estimates generative AI alone could add $2.6–4.4 trillion to the global economy annually — before counting the compounding effects of applied machine intelligence across industries.

McKinsey Global Institute
Frontier ii

Autonomous systems

Sensing, robotics, and machines that act in the physical world — the only technologies that scale care, monitoring, and presence without scaling headcount.

The world is aging into a structural care gap: 2.1 billion people over 60 by 2050, against a WHO-projected shortfall of 10 million health workers by 2030. Autonomy is not a convenience here; it is the arithmetic answer.

WHO, Ageing & Health · WHO, Health Workforce
Frontier iii

Engineered biology

Reading, writing, and designing biology — moving medicine and human performance from observation to engineering, with fertility among its most consequential applications.

The McKinsey Global Institute sizes the "Bio Revolution" at up to $4 trillion of direct annual economic impact over the coming decades — and estimates as much as 45% of the global disease burden is addressable with science conceivable today.

McKinsey Global Institute, The Bio Revolution

03 The provocation

Equity should buy more than advice.

Traditional investors provide capital, introductions, and periodic counsel. Embers accepts a mandate. We work alongside the founder to build the commercial engine — positioning, pricing, demand generation, partnerships, distribution, enterprise access, and revenue execution.

Advice is optional. Accountability is not.

04 The problem

Capital can accelerate a company. It can also create dependency.

Too many early-stage companies become highly skilled at raising the next round before proving that customers will pay. Embers is built on a different conviction: the goal is not simply to make a company more fundable. The goal is to make it more economically real.

Revenue is not merely a financial outcome. It is evidence that value has been created.

35%

of failed startups cite "no market need" — the single most common cause in post-mortem analyses.

CB Insights, startup post-mortems

~70%

of high-growth startups scale prematurely — spending on growth before the commercial model is proven.

Startup Genome

72%

of new products miss their revenue or profit targets — most often for reasons of pricing and positioning, not product.

Simon-Kucher, Global Pricing Study

30 v 18

success rates, in percent, of proven founders versus first-timers. Commercial experience is a transferable asset — it can be brought in.

Gompers, Kovner, Lerner & Scharfstein, Harvard

The gap is commercial, not conceptual.

05 The mandate

We do not stand beside the work. We enter it.

Embers contributes three forms of capital — financial, operational, and relationship — as connected forces feeding one revenue system. That system, compounding with everything the founder builds, is what converts innovation into value creation and sustainable growth.

Cash for runway and strategic speed. Experienced operators who design and build the revenue engine. Working access to customers, channels, partners, talent, and industry decision-makers — accumulated across decades of operating, and spent deliberately on behalf of our companies. The revenue system is our accountability; joined with the founder's product, team, and vision, it compounds into value creation and sustainable growth.

06 The model — in four movements

Movement i — Equity

We take equity.

We invest capital and take a defined share of the cap table — units on the same thread as yours. From day one, our economics are bound to the company's.

Movement ii — Accountability

We take responsibility.

Our units go to work inside the company — on pricing, customer access, and the selling system. Ownership, in our model, is an obligation to build.

Movement iii — Revenue

We accelerate what matters.

Revenue begins to run through the whole cap table — a current, not a chart. Customers are counted, not projected; results are repeatable, not anecdotal.

Movement iv — Ownership

You take it back.

As pre-agreed milestones are reached, our units return to the founder — the current keeps running without us. What remains of our stake is a period, not a claim.

07 The revenue mandate

Revenue acceleration is not a promise around the edges. It is our central responsibility.

Ten disciplines, one system. Select any of them — each carries our perspective and the research behind it.

We are not passive capital. We are accountable capital.

08 Where we run deep

Three disciplines. One connected commercial engine.

Our operating depth is not general. It is concentrated where revenue is actually decided today — and backed by extensive access to the companies, channels, and decision-makers that constitute markets.

Discipline i

Revenue acceleration in the omni-world

Buying is no longer sequential. Customers move across direct, retail, marketplace, social, and enterprise channels — often within a single decision. Most early-stage companies build for one channel; we build revenue systems designed for how buying actually happens now: unified pricing architecture, channel economics that don't cannibalize each other, and demand that compounds across touchpoints.

In a study of 46,000 shoppers, 73% moved across multiple channels — and omnichannel customers spent more and stayed more loyal than single-channel customers. On the B2B side, buyers now routinely use ten or more channels to interact with suppliers, roughly double the count of a decade ago.

Harvard Business Review · McKinsey B2B Pulse
Discipline ii

Brand stewardship

Performance spend harvests demand. Brand plants it. We treat brand as a compounding asset the balance sheet can't see — defining what it stands for, pricing what it's worth, and defending it through every channel and partnership decision. Stewardship, not just marketing: the discipline of making a young company's most durable asset stronger with every commercial choice.

The effectiveness research is unambiguous: sustained brand-building drives long-term growth and pricing power, with the strongest results near a 60/40 balance of brand to activation — and portfolios of the world's strongest brands have consistently outperformed the S&P 500.

Binet & Field, "The Long and the Short of It" · Kantar BrandZ
Discipline iii

Market making

The biggest outcomes don't win existing markets — they define new ones. Market making is a craft: name the category, build the narrative, stack the proof, and assemble the ecosystem of customers, partners, and channels that makes the category real. We hold extensive, working access to the companies and decision-makers that constitute markets — retailers, platforms, distributors, enterprise buyers — and we spend that access deliberately, on behalf of the companies we build.

Among America's fastest-growing companies studied over a three-year window, category creators were a small minority — yet captured 53% of incremental revenue growth and 74% of incremental market capitalization.

Yoon & Deeken, Harvard Business Review

09 Positions we hold

Convictions, held with evidence.

P—01

Distribution decides more outcomes than product.

Post-mortem data is dominated by demand-side causes, not engineering ones. Great products die of empty pipelines every day — which is why we treat customer access as capital, not as a favor.

P—02

Pricing is the most neglected lever in early-stage growth.

Most companies set price once, early, and under-confidently — then compound the discount for years. We revisit pricing architecture as often as we revisit the product roadmap.

P—03

Brand is what makes revenue repeatable.

Activation converts demand that already exists; brand creates the demand of the next quarter. A company that only harvests will eventually run out of field.

P—04

Categories are made, not found.

Markets are constructed from narrative, proof, and ecosystem. The companies that do the constructing set the rules everyone else competes under.

P—05

The best capability is the kind that stays.

An engine that requires our presence is not an engine — it's a dependency. Everything we build is designed to run inside the company after we step back.

10 The economic innovation

Our equity has a destination.

At the beginning of the partnership, Embers and the founder agree on the principles governing a future exit. As the company creates revenue and reaches defined milestones, the founder earns the opportunity to reclaim the equity held by Embers on pre-agreed economic terms.

The Embers Earnback Model

Equity founders can earn back as the business grows.

For founders: a path back to greater ownership. For Embers and its investment partners: a more deliberate route to realized returns and capital recycling — without depending exclusively on an acquisition or public offering.

The principle

The exit is designed at entry.

11 Two sides, one model

For founders

Accelerate without surrendering the future.

Capital, commercial capability, and active revenue execution — with a defined path to regain ownership as the company succeeds.

For investment partners

Invest earlier. Build value directly. Realize returns deliberately.

Participate in businesses where Embers helps manufacture the commercial outcome and establishes the principles of liquidity from the beginning.

12 In the work — examples

Breakthroughs, becoming markets.

Three examples from the portfolio — each a frontier technology applied to fertility or longevity, each with a commercial engine under construction. Examples, not the census.

Engineered biology → fertility

AlphaSperm®

alphasperm.com ↗

AlphaSperm® reimagines male reproductive health through a science-led formulation of precision micronutrients and antioxidants designed to optimize fertility potential.

Sperm counts have fallen more than 50% in five decades, with the decline accelerating since 2000. The WHO estimates 1 in 6 adults experience infertility — and male factor contributes in roughly half of cases, while receiving a fraction of the attention and innovation.

Levine et al., Human Reproduction Update · WHO, Infertility Prevalence 2023
Market access → family offices & pre-IPO

Northloom®

Engagements by referral

Northloom® is a global advisory and market-access platform helping family offices compound multigenerational value — and pre-IPO companies accelerate growth in markets being reshaped by frontier technologies.

Both sides of its market are compounding: industry research projects the number of single family offices passing 10,000 this decade, with assets under management in the trillions — while companies now stay private a decade or more, shifting the capture of growth to pre-IPO investors and the platforms that reach them.

Deloitte Private, Family Office Insights · University of Florida IPO data
Computational intelligence + autonomous systems → longevity

AllWell®

In development

AllWell® combines AI, connected sensing and robotics to help families care for aging loved ones across oceans — extending independence, visibility and peace of mind.

By 2050, 2.1 billion people will be over 60 — double 2020 — while 77% of adults 50+ want to age in their own homes and the WHO projects a 10 million health-worker shortfall by 2030. The care gap is structural; scalable technology is the only arithmetic answer.

WHO, Ageing & Health · AARP, Home & Community Preferences

Additional investments across the focus — announced as the work matures

The founder path

Accelerate without surrendering the future.

You've built something real. The commercial engine is the gap. We close it with you — capital, senior operators in the work, working market access — and a written path to take back every share we hold.

F—01 What changes on day one

Three things you get that a check can't buy.

01

A revenue mandate with our name on it

We don't recommend a go-to-market; we're accountable for building one. Positioning, pricing, demand, channels, and the selling system — worked, not workshopped.

02

Senior operators inside the work

Commercial leadership before you can justify hiring it — pattern recognition from decades of operating, applied to your specific inflection point.

03

Doors that open

Retailers, platforms, distributors, enterprise buyers, talent. Relationship capital accumulated over careers — spent deliberately, on your behalf.

Why it matters: founders who have built before succeed at roughly 30% versus 18% for first-timers. Experience is a transferable asset — with Embers, you bring it in rather than wait to accumulate it.

Gompers, Kovner, Lerner & Scharfstein, Harvard

F—02 The deal, from your seat

You always know the path back. It's in the contract, not the pitch.

Step i

Sign

Investment, equity, milestones, and the earn-back schedule — all agreed before the work begins. No ambiguity to renegotiate later.

Step ii

Build

We embed with you and your team on the commercial engine. Tight cadence, shared scorecard, real work.

Step iii

Prove

Milestones are evidence-based and transparent: customers, revenue, repeatability. You see the same numbers we do.

Step iv

Reclaim

As milestones are met, equity returns to you on the pre-agreed terms. The capability we built stays inside your company.

The Embers Earnback Model: our equity has a destination — you. And because our economics depend on the milestones being reached, the incentives point one direction: build your revenue, fast and durably.

F—03 The alternatives, honestly

Every path gives you something. Only one is built to give it back.

What you need
Traditional VC
Consultants
Embers
Capital at risk
●
○
●
Hands inside the commercial work
○
●
●
Economics tied to your revenue outcome
partial
○
●
Working market access, spent for you
intro-level
○
●
A written path to reclaim your equity
○
n/a
●
Designed to become unnecessary
○
rarely
●

F—04 What we ask of you

Access, candor, speed — and a willingness to do the work side by side.

We work with a small number of companies at a time, in our focus: frontier technologies applied to fertility and longevity, and select pre-IPO companies where market access changes the slope. The best fits have a credible product with early evidence of customer value, a specific commercial inflection point, and a founder who wants a working partner — not an occasional commentator.

Embers is not the right partner for founders seeking passive capital or occasional introductions.

One discipline we'll hold together: roughly 70% of high-growth startups scale prematurely — spending ahead of a proven model. We sequence: prove the motion, then fund it. It's how the disciplined minority wins.

Startup Genome

The investor path

Invest earlier. Build value directly. Realize returns deliberately.

Embers is accountable capital with a designed exit: we invest where our operating depth and market access can influence revenue — the driver of value — and we establish the principles of liquidity at entry.

I—01 The thesis

Where breakthroughs become markets.

We back founders applying frontier technologies — computational intelligence, autonomous systems, and engineered biology — to fertility and longevity, and we partner with select pre-IPO companies where our market access can turn innovation into accelerated growth.

$2.6–4.4T

estimated annual economic potential of generative AI alone — before broader applied machine intelligence.

McKinsey Global Institute

up to $4T

direct annual impact of the Bio Revolution; up to 45% of global disease burden addressable with science conceivable today.

McKinsey Global Institute

2.1B

people over 60 by 2050 — double 2020 — against a projected 10-million health-worker shortfall by 2030.

WHO

1 in 6

adults experience infertility, while sperm counts have fallen more than 50% in five decades — an accelerating decline.

WHO · Levine et al.

Structural demand, mispriced by inattention.

I—02 Why the math is different

Venture returns follow a power law. The question is whether the GP can influence the driver.

A small share of deals drives the majority of venture returns — and the driver of those outcomes is commercial traction, not capital raised. Most firms select for it and wait. Embers operates on it directly: the same operating depth and market access described across this site, applied as the core of the investment strategy rather than a service around its edges.

And liquidity is designed, not awaited. With companies staying private a decade or more — median age at IPO has roughly tripled since 1999 — exit windows are unreliable. The Earnback Model creates an additional, deliberate realization path: as founders reclaim equity on pre-agreed terms, capital returns and recycles without depending exclusively on an acquisition or public offering.

Stated plainly for diligence: Embers is structurally designed to influence revenue and liquidity — not to guarantee them. Concentration, operating involvement, and milestone-based governance are how that design is enforced.

Embers Ventures — investment discipline

I—03 The discipline

Concentrated. Embedded. Measured by what remains.

01

Concentration over coverage

A small number of positions at a time, each receiving real operating attention. We would rather be decisive in few than diluted across many.

02

Milestone governance

Every engagement is structured around evidence: customers, revenue, repeatability. Progress is measured on a shared scorecard, not narrative.

03

Proprietary access

Deal flow originates from operating relationships — founders, retailers, platforms, enterprise buyers, and the Northloom advisory network — not from auctions.